![](/img/cover-not-exists.png)
NPM-ALK modulates the p53 tumour suppressor pathway in a JNK and PI 3-Kinase dependent manner: MDM-2 is a potential therapeutic target for the treatment of ALK-expressing malignancies
Y. Cui, A. Kerby, F.K.E. McDuff, S.D. TurnerVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)71315-6
File:
PDF, 90 KB
english, 2008